Worldwide Molecular Quality Control Industry to 2029 – Growing Demand for External Standard Evaluation Support is Driving the Market – ResearchAndMarkets.com

Worldwide Molecular Quality Control Industry to 2029 – Growing Demand for External Standard Evaluation Support is Driving the Market – ResearchAndMarkets.com




Worldwide Molecular Quality Control Industry to 2029 – Growing Demand for External Standard Evaluation Support is Driving the Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Molecular Quality Control Market Analysis by Product, by Analyte type by Application, End user and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The molecular quality control market size is estimated to be USD 324 million in 2021 and is expected to witness a CAGR of 9.17% during the forecast period 2022-2029.

Companies Mentioned

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Bio-Rad Laboratories Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Randox Laboratories Ltd. (UK)
  • LGC Limited (UK)
  • Abbott Laboratories (US)
  • Fortress Diagnostics (UK)
  • SERO AS (Norway)
  • Anchor Molecular (US)
  • Ortho-Clinical Diagnostics Inc. (US)
  • Quidel Corporation (US)
  • Sun Diagnostics LLC (US)
  • Seegene Inc. (South Korea)
  • ZeptoMetrix LLC (US)
  • Qnostics (UK)
  • Bio-Techne Corporation (US)
  • Microbiologics Inc. (US)
  • Microbix Biosystems Inc. (Canada)
  • SpeeDx Pty. Ltd. (Australia)
  • Maine Molecular Quality Controls Inc. (US)
  • Grifols S.A. (Spain)

The increased adoption of third-party quality controls, the escalating number of accredited clinical laboratories, the growing demand for external standard evaluation support, increasing government funding to cover genomics projects are some of the key drivers for the market growth. Additionally, increasing demand for personalised medicines, declining sequencing costs, and the rising prevalence of infectious diseases, cancer, and genetic diseases is projected to drive the market growth in near future. However, limited budget in hospitals and additional cost associated with quality control are expected to restrain the market growth.

By Product

Based on product, the market is bifurcated into instrument-specific controls and independent controls. In 2021, the independent controls segment accounted for the highest revenue share due to the growing number of authorized laboratories and regulatory organizations’ regulations for the application of quality controls to assure the correctness of diagnostic test findings.

By Analyte Type

On the basis of analyte type, the market is bifurcated into multi-analyte controls and single-analyte controls. In 2021, the single-analyte segment accounted for the highest revenue share owing to the benefits of using single-analyte controls, including its ease of analysis and interpretation and minimal danger of cross-reactivity, and the widespread use of singleplex tests in hospitals.

By Application

Based on application, the market is segregated into oncology testing, genetic testing, infectious disease diagnostics, and other application. In 2021, the infectious disease diagnostics segment accounted for the highest revenue share due to the growing understanding of how to employ molecular diagnostic tools to effectively stop the incidence and spread of infectious illnesses, the advancement of sophisticated tests for infectious illnesses, and a rise in infectious disease prevalence that is large.

By End-user

On the basis of end user, the market is categorized into hospitals, diagnostic laboratories, academic & research institutes, IVD manufacturers & CROs, and others. In 2021, the diagnostic laboratories segment accounted for the highest revenue share owing to rising number of authorised diagnostic labs.

Regional Markets

In 2021, North America region accounted for the highest revenue in the molecular quality control market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing acceptance of bio simulation, developed healthcare infrastructure in the U.S and Canada, presence of leading players in this region, and government funding. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to developing healthcare infrastructure, growing disposable income, and rising healthcare awareness in this region.

Key Topics Covered:

1. Research Methodology

2. Introduction: Molecular Quality Control

3. Executive Summary

4. Market Dynamics

4.1. Market Drivers

4.2. Market Restraint

4.3. Market Opportunities

4.4. Market Trends

4.5. Market Challenges

5. Market Environment Analysis

5.1. Porter’s 5 Forces Analysis

5.2. PESTEL Analysis

5.3. Value Chain Analysis

5.4. SWOT Analysis

5.5. Benchmark

6. COVID-19 Impact Analysis: Molecular Quality Control Market

6.1. COVID-19: Overview

6.2. COVID-19 Impact on the Global Market

6.3. COVID-19 Impact on the Regional Markets

7. Market Analysis by Product

8. Market Analysis by Analyte Type

9. Market Analysis by Application

10. Market Analysis by End user

11. Regional Market Analysis

11.1.Regional Market Trends

11.2.Regional Market: Comparative Analysis

12. North America Molecular Quality Control Market

13. Europe Molecular Quality Control Market

14. Asia Pacific Molecular Quality Control Market

15. Latin America Molecular Quality Control Market

16. MEA Molecular Quality Control Market

17. Competitor Analysis

17.1.Market Share Analysis, 2021 & 2029

17.2.Competitive Mapping

17.3.Key Players Market Place Analysis

17.4.Major Recent Developments

18. Company Profiles

19. Conclusion & Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/ann99o

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900